{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T10:30:11Z","timestamp":1776335411270,"version":"3.51.2"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>HIV-exposed uninfected (HEU) infants have increased risk of tuberculosis (TB). Testing for <jats:italic toggle=\"yes\">Mycobacterium tuberculosis<\/jats:italic> (Mtb) infection is limited by reduced Quantiferon (QFT) sensitivity in infants and tuberculin skin test (TST) cross-reactivity with Bacillus Calmette\u2013Gu\u00e9rin vaccine. Our objective is to assess if non-IFN\u03b3 cytokine responses to Mtb-specific antigens have improved sensitivity in detecting Mtb infection in HEU infants compared with QFT.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>HEU infants were enrolled in a randomized clinical trial of isoniazid preventive therapy (IPT) to prevent Mtb infection in Kenya (N = 300) and assessed at 12 months postrandomization (14 months of age) by TST and QFT-Plus. Non-IFN\u03b3 cytokine secretion (IL2, TNF, IP10, N = 229) in QFT-Plus supernatants was measured using Luminex assay. Logistic regression was used to assess the effect of IPT on Mtb infection outcomes in HEU infants.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Three of 251 (1.2%) infants were QFT-Plus positive. Non-IFN\u03b3 Mtb antigen-specific responses were detected in 12 additional infants (12\/229, 5.2%), all TST negative. IPT was not associated with Mtb infection defined as any Mtb antigen-specific cytokine response (odds ratio = 0.7, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.54). Mtb antigen-specific IL2\/IP10 responses had fair correlation (\u03c4 = 0.25). Otherwise, non-IFN\u03b3 cytokine responses had minimal correlation with QFT-Plus and no correlation with TST size.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>We detected non-IFNg Mtb antigen-specific T-cell responses in 14-month HEU infants. Non-IFNg cytokines may be more sensitive than IFNg in detecting infant Mtb infection. IPT during the first year of life was not associated with Mtb infection measured by IFNg, IL2, IP10 and TNF Mtb-specific responses.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000003254","type":"journal-article","created":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T17:05:58Z","timestamp":1626282358000},"page":"922-929","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Non-IFN\u03b3 Whole Blood Cytokine Responses to Mycobacterium tuberculosis Antigens in HIV-exposed Infants"],"prefix":"10.1097","volume":"40","author":[{"given":"Christine","family":"Anterasian","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of Washington, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex J.","family":"Warr","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Washington, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia M.","family":"Lacourse","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Washington, Seattle, Washington"},{"name":"Department of Global Health, University of Washington, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Kinuthia","sequence":"additional","affiliation":[{"name":"Department of Research and Programs, Kenyatta National Hospital, Nairobi, Kenya"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbra A.","family":"Richardson","sequence":"additional","affiliation":[{"name":"Department of Global Health, University of Washington, Seattle, Washington"},{"name":"Department of Biostatistics, University of Washington, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felicia K.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Washington, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Matemo","sequence":"additional","affiliation":[{"name":"Department of Research and Programs, Kenyatta National Hospital, Nairobi, Kenya"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Maleche-Obimbo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Child Health, Kenyatta National Hospital, Nairobi, Kenya."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace C.","family":"John Stewart","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Washington, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas R.","family":"Hawn","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Washington, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,7,8]]},"reference":[{"key":"R1-20250615","doi-asserted-by":"crossref","first-page":"e898","DOI":"10.1016\/S2214-109X(17)30289-9","article-title":"The global burden of tuberculosis mortality in children: a mathematical modelling study.","volume":"5","author":"Dodd","year":"2017","journal-title":"Lancet Glob Health"},{"key":"R2-20250615","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1473-3099(16)30474-1","article-title":"Mortality in children diagnosed with tuberculosis: a systematic review and meta-analysis.","volume":"17","author":"Jenkins","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"R4-20250615","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/INF.0b013e318214b915","article-title":"The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis.","volume":"30","author":"Machingaidze","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R5-20250615","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.5588\/ijtld.10.0631","article-title":"Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis.","volume":"15","author":"Mandalakas","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"R6-20250615","first-page":"225","article-title":"Tuberculosis exposure in HIV-exposed infants in a high-prevalence setting.","volume":"12","author":"Cotton","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"R7-20250615","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJMoa1011214","article-title":"Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children.","volume":"365","author":"Madhi","year":"2011","journal-title":"N Engl J Med"},{"key":"R8-20250615","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00383","article-title":"The immune system of HIV-exposed uninfected infants.","volume":"7","author":"Abu-Raya","year":"2016","journal-title":"Front Immunol"},{"key":"R9-20250615","doi-asserted-by":"crossref","first-page":"454","DOI":"10.5588\/ijtld.14.0608","article-title":"Immunogenicity of BCG in HIV-exposed and non-exposed infants following routine birth or delayed vaccination.","volume":"19","author":"Hesseling","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"key":"R10-20250615","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1097\/QAD.0000000000000292","article-title":"In-utero exposure to maternal HIV infection alters T-cell immune responses to vaccination in HIV-uninfected infants.","volume":"28","author":"Kidzeru","year":"2014","journal-title":"AIDS"},{"key":"R11-20250615","first-page":"278","article-title":"The clinical epidemiology of childhood pulmonary tuberculosis: a critical review of literature from the pre-chemotherapy era.","volume":"8","author":"Marais","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"R12-20250615","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S2213-2600(19)30137-7","article-title":"Paediatric tuberculosis transmission outside the household: challenging historical paradigms to inform future public health strategies.","volume":"7","author":"Martinez","year":"2019","journal-title":"Lancet Respir Med"},{"key":"R13-20250615","first-page":"149","article-title":"Age-related tuberculosis incidence and severity in children under 5 years of age in Cape Town, South Africa.","volume":"14","author":"Moyo","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"R14-20250615","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S2352-4642(19)30375-X","article-title":"Infectious morbidity of breastfed, HIV-exposed uninfected infants under conditions of universal antiretroviral therapy in South Africa: a prospective cohort study.","volume":"4","author":"le Roux","year":"2020","journal-title":"Lancet Child Adolesc Health"},{"key":"R15-20250615","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial.","volume":"381","author":"Tameris","year":"2013","journal-title":"Lancet"},{"key":"R17-20250615","article-title":"A randomized controlled trial of isoniazid to prevent Mycobacterium tuberculosis infection in Kenyan HIV-exposed uninfected infants.","author":"LaCourse","journal-title":"Clin Infect Dis"},{"key":"R18-20250615","doi-asserted-by":"crossref","first-page":"e034308","DOI":"10.1136\/bmjopen-2019-034308","article-title":"Infant TB Infection Prevention Study (iTIPS): a randomised trial protocol evaluating isoniazid to prevent M. tuberculosis infection in HIV-exposed uninfected children.","volume":"10","author":"LaCourse","year":"2020","journal-title":"BMJ Open"},{"key":"R19-20250615","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/j.1469-0691.2009.03104.x","article-title":"Detection of interleukin-2 in addition to interferon-gamma discriminates active tuberculosis patients, latently infected individuals, and controls.","volume":"16","author":"Biselli","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"R20-20250615","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1365-3083.2012.02776.x","article-title":"The responses of multiple cytokines following incubation of whole blood from TB patients, latently infected individuals and controls with the TB antigens ESAT-6, CFP-10 and TB7.7.","volume":"76","author":"Kim","year":"2012","journal-title":"Scand J Immunol"},{"key":"R21-20250615","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1128\/JCM.00117-12","article-title":"Multicytokine detection improves latent tuberculosis diagnosis in health care workers.","volume":"50","author":"Rubbo","year":"2012","journal-title":"J Clin Microbiol"},{"key":"R22-20250615","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jinf.2013.08.005","article-title":"Cytokine responses to quantiferon peptides in pediatric tuberculosis: a pilot study.","volume":"68","author":"Armand","year":"2014","journal-title":"J Infect"},{"key":"R23-20250615","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CVI.00620-13","article-title":"Identification of immunological biomarkers which may differentiate latent tuberculosis from exposure to environmental nontuberculous mycobacteria in children.","volume":"21","author":"Hur","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"R24-20250615","first-page":"1548","article-title":"Cytokine responses to QuantiFERON\u00ae peptides, purified protein derivative and recombinant ESAT-6 in children with tuberculosis.","volume":"14","author":"Lighter-Fisher","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"R25-20250615","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jinf.2017.04.009","article-title":"Cytokine\/chemokine secretion for detecting tuberculosis in quantiferon supernatants from HIV+ and HIV- children.","volume":"75","author":"Jeljeli","year":"2017","journal-title":"J Infect"},{"key":"R26-20250615","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1183\/09031936.00055508","article-title":"Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis.","volume":"32","author":"Ruhwald","year":"2008","journal-title":"Eur Respir J"},{"key":"R27-20250615","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3109\/00365548.2011.632644","article-title":"Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study.","volume":"44","author":"Alsleben","year":"2012","journal-title":"Scand J Infect Dis"},{"key":"R28-20250615","doi-asserted-by":"crossref","first-page":"e12577","DOI":"10.1371\/journal.pone.0012577","article-title":"Is IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons?","volume":"5","author":"Goletti","year":"2010","journal-title":"PLoS One"},{"key":"R29-20250615","doi-asserted-by":"crossref","first-page":"e001751","DOI":"10.1136\/bmjopen-2012-001751","article-title":"Evaluation of the filter paper IP-10 tests in school children after exposure to tuberculosis: a prospective cohort study with a 4-year follow-up.","volume":"2","author":"Tuuminen","year":"2012","journal-title":"BMJ Open"},{"key":"R30-20250615","doi-asserted-by":"crossref","first-page":"589471","DOI":"10.1155\/2015\/589471","article-title":"Blood or Urine IP-10 cannot discriminate between active tuberculosis and respiratory diseases different from tuberculosis in children.","volume":"2015","author":"Petrone","year":"2015","journal-title":"Biomed Res Int"},{"key":"R31-20250615","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1586\/erm.11.97","article-title":"IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions.","volume":"12","author":"Ruhwald","year":"2012","journal-title":"Expert Rev Mol Diagn"},{"key":"R32-20250615","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/INF.0b013e3182611152","article-title":"Interferon gamma-induced protein-10 concentrations in children with previous tuberculosis infections and disease.","volume":"31","author":"Bihari","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"R33-20250615","doi-asserted-by":"crossref","first-page":"e23733","DOI":"10.1371\/journal.pone.0023733","article-title":"Can interferon-gamma or interferon-gamma-induced-protein-10 differentiate tuberculosis infection and disease in children of high endemic areas?","volume":"6","author":"Yassin","year":"2011","journal-title":"PLoS One"},{"key":"R34-20250615","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3389\/fimmu.2020.00929","article-title":"Maternal latent Mycobacterium tuberculosis does not affect the infant immune response following BCG at birth: an observational longitudinal study in Uganda.","volume":"11","author":"Lubyayi","year":"2020","journal-title":"Front Immunol"},{"key":"R35-20250615","doi-asserted-by":"crossref","first-page":"e0187313","DOI":"10.1371\/journal.pone.0187313","article-title":"A borderline range for Quantiferon Gold In-Tube results.","volume":"12","author":"Jonsson","year":"2017","journal-title":"PLoS One"},{"key":"R36-20250615","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1542\/peds.2007-3618","article-title":"Latent tuberculosis diagnosis in children by using the QuantiFERON-TB Gold In-Tube test.","volume":"123","author":"Lighter","year":"2009","journal-title":"Pediatrics"},{"key":"R37-20250615","doi-asserted-by":"crossref","first-page":"e20191930","DOI":"10.1542\/peds.2019-1930","article-title":"Interferon-\u03b3 release assays in children <15 years of age.","volume":"145","author":"Ahmed","year":"2020","journal-title":"Pediatrics"},{"key":"R38-20250615","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1183\/09031936.00022710","article-title":"Diagnosing TB infection in children: analysis of discordances using in vitro tests and the tuberculin skin test.","volume":"37","author":"Altet-G\u00f3mez","year":"2011","journal-title":"Eur Respir J"},{"key":"R39-20250615","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1309\/LMCQLO8PG0IZ5APX","article-title":"Discordance between tuberculin skin test and interferon-\u03b3 release assay in children younger than 5 years who have been vaccinated with Bacillus Calmette-Gu\u00e9rin.","volume":"3","author":"Pavi\u0107","year":"2015","journal-title":"Lab Med"},{"key":"R40-20250615","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.5588\/ijtld.10.0770","article-title":"Tuberculin skin test and QuantiFERON\u00ae assay in young children investigated for tuberculosis in South Africa.","volume":"15","author":"Moyo","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"R41-20250615","doi-asserted-by":"crossref","first-page":"e260","DOI":"10.1097\/INF.0000000000000399","article-title":"Influence of age and nutritional status on the performance of the tuberculin skin test and QuantiFERON-TB gold in-tube in young children evaluated for tuberculosis in Southern India.","volume":"33","author":"Jenum","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R42-20250615","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41390-019-0383-y","article-title":"Ontogeny of cytokine responses to PHA from birth to adulthood.","volume":"86","author":"Jeljeli","year":"2019","journal-title":"Pediatr Res"},{"key":"R43-20250615","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3389\/fped.2017.00255","article-title":"Influence of age and other factors on cytokine expression profiles in healthy Children-A systematic review.","volume":"5","author":"Decker","year":"2017","journal-title":"Front Pediatr"},{"key":"R44-20250615","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/QAD.0000000000000536","article-title":"The impact of HIV exposure and maternal Mycobacterium tuberculosis infection on infant immune responses to Bacille Calmette-Gu\u00e9rin vaccination.","volume":"29","author":"Jones","year":"2015","journal-title":"AIDS"},{"key":"R45-20250615","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00430-017-0501-6","article-title":"Alternative Quantiferon cytokines for diagnosis of children with active tuberculosis and HIV co-infection in Ghana.","volume":"206","author":"Lundtoft","year":"2017","journal-title":"Med Microbiol Immunol"},{"key":"R46-20250615","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jinf.2016.08.013","article-title":"Immune response to Mycobacterium tuberculosis in young contacts with discordant immunological test results.","volume":"73","author":"Jeljeli","year":"2016","journal-title":"J Infect"},{"key":"R47-20250615","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1128\/CVI.13.2.246-252.2006","article-title":"Gamma interferon production in response to Mycobacterium bovis BCG and Mycobacterium tuberculosis antigens in infants born to human immunodeficiency virus-infected mothers.","volume":"13","author":"Van Rie","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"R48-20250615","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jaci.2009.03.040","article-title":"Neonatal innate cytokine responses to BCG controlling T-cell development vary between populations.","volume":"124","author":"van den Biggelaar","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"R49-20250615","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.1128\/IAI.72.11.6401-6407.2004","article-title":"Novel human in vitro system for evaluating antimycobacterial vaccines.","volume":"72","author":"Kampmann","year":"2004","journal-title":"Infect Immun"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003254","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T16:01:05Z","timestamp":1750003265000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,8]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003254","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,8]]}}}